Category: eleven

Fidia Pharma USA Inc will be exhibiting at the Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) in San Francisco, February 7-11, 2012. Please come and see us at booth 4220 (Hall E). We will be exhibiting our flagship product HYALGAN® (sodium hyaluronate, intra-articular injections for the treatment of pain in osteoarthritis of […]

Fidia Pharma USA Inc will be exhibiting at the forthcoming Annual Scientific Meeting of the American College of Rheumatology in Chicago, 5-9 November 2011. Please come and see us at booth 1032. We will be exhibiting our flagship product HYALGAN® (sodium hyaluronate, intra-articular injections for the treatment of pain in osteoarthritis of the knee. HYALGAN® […]

Fidia Pharma USA Inc, to distribute the product online Hyalo GYN® supplements the body’s natural hydrating function, and is intended for use as a hydrating /lubricating agent in patients suffering from vaginal dryness of various origins, and micro-lesions of the epithelium that can result from a poorly lubricated environment. It was developed especially for women […]

Commercial rights to Hyalgan transitioned from Sanofi back to Fidia, the brand’s owner and manufacturer Wholly-owned subsidiary, Fidia Pharma USA Inc, engages Interpace BioPharma, LLC. to handle distribution and promotional support PARSIPPANY, N.J., Sept. 26, 2011 /PRNewswire/ — Fidia Farmaceutici S.p.A. (“Fidia”) announced today that it has assumed responsibility for distributing and promoting the osteoarthritis […]